《中国期刊全文数据库》收录期刊
《中国核心期刊(遴选)数据库》收录期刊
《中文科技期刊数据库》收录期刊

外科研究与新技术 ›› 2018, Vol. 7 ›› Issue (2): 93-96.doi: 10.3969/j.issn.2095-378X.2018.02.004

• 论 著 • 上一篇    下一篇

P504s、P63、PSMA及Ck34βE12在前列腺良恶性病变鉴别中的意义

李国成   

  1. 山东省菏泽市牡丹区中医医院外科,菏泽274000
  • 收稿日期:2018-03-28 出版日期:2018-06-28 发布日期:2019-12-10
  • 作者简介:李国成(1972—),男,本科,主治医师,从事泌尿外科临床工作者;电子信箱:lie9401@163.com

Significance of P504s, P63, PSMA, and Ck34βE12 in identification of benign and malignant prostate lesions

LI Guocheng   

  1. Department of Surgery, Traditional Chinese Medicine Hospital of Heze City of Shandong Province, Heze 274000, China
  • Received:2018-03-28 Online:2018-06-28 Published:2019-12-10

摘要: 目的 探究P504s、P63、PSMA及Ck34βE12在前列腺良恶性病变鉴别中的意义。方法 选取2014年1月—2016年12月收治的直肠B超引导下的手术切除标本112例作为研究对象,所获标本均进行石蜡切片,检测切片中P504S、P63、PSMA及Ck34βE12,根据阳性细胞比例分级。对单独和联合检测P504S、P63、PSMA及Ck34βE12诊断前列腺癌的准确度,灵敏性及特异性进行统计。结果 P504S在Pca患者中阳性率为100.00%,弥散阳性率高达62.75%,显著高于AAH、BCH和BPH的表达量;P63和Ck34βE12在Pca的阳性率为0%,而在HGPIN、AAH、BCH和BPH中的表达量均为100.00%;PSMA在Pca、HGPIN的阳性率为98.04%和90.91%,在AAH、BCH和BPH中的阳性率分别为13.33%、11.11%和9.52%;P504S、P63、PSMA及Ck34βE12联合检测对前列腺癌诊断的准确度,灵敏性及特异性分别达到100.00%、97.85%和98.24%,具有一定的临床诊断价值。结论 对于前列腺癌的诊断,P504S、P63、PSMA及Ck34βE12联合检测能够显著增加对前列腺癌诊断的准确度,特异性和灵敏度。

关键词: 前列腺癌, P504S, P63, PSMA, Ck34βE12

Abstract: Objective To explore the significance of P504s, P63, PSMA, and Ck34βE12 in the identification of benign and malignant prostate lesions.Methods A total of 112 surgical resection specimens of transrectal ultrasound guided prostate biopsy were collected from the Traditional Chinese Medicine Hospital of Heze City of Shandong Province from January 2014 to December 2016.All specimens were prepared for paraffin section and detected for P504s, P63, PSMA, and Ck34βE12.According to the proportion of positive cells, the detection Results were classified as follows.The accuracy, sensitivity, and specificity of P504S, P63, PSMA, and Ck34βE12 detected separately and jointly in the diagnosis of prostate cancer were compared.Results The positive rate of P504s in prostate cancer patients was 100.00%, and the dispersion positive rate was up to 62.75%, significantly higher than those in the AAH, BCH, and BPH patients.The positive rates of P63 and Ck34βE12 in prostate cancer patients were both 0%, while those in the HGPIN, AAH, BCH, and BPH patients were all 100.00%.The positive rates of PSMA in prostate cancer and HGPIN patients were 98.04% and 90.91%, respectively, while those in the AAH, BCH, and BPH patients were 13.33%, 11.11%, and 9.52%, respectively.The accuracy, sensitivity, and specificity of combined detection of P504s, P63, PSMA, and Ck34 reached 100.00%, 97.85%,and 98.24%, respectively, showing clinical diagnostic value.Conclusion For the diagnosis of prostate cancer, combined detection of P504s, P63, PSMA, and Ck34βE12 could significantly increase the accuracy, sensitivity, and specificity.

Key words: Prostate cancer, P504s, P63, PSMA, Ck34βE12

中图分类号: